Dec 31, 2021 05:09 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 31 - Guizhou bailing announced that the company's wholly-owned subsidiary, Guizhou bailing enterprise group Zhengxin Pharmaceutical Co., Ltd. ("Zhengxin pharmaceutical") recently received the notice on approval of supplementary drug application approved and issued by the State Drug Administration ("State Drug Administration"). The name of the drug is norfloxacin capsule. Application contents: 1. Application for consistency evaluation. There is a change in the prescription process. 2. Improve quality standards. 3. Complete the pre meal bioequivalence study.